MVP: Sullivan & Cromwell's Davis Wang
Law360 (October 30, 2023, 1:07 PM EDT) -- Through work on notable transactions including Amgen's purchase of Horizon Therapeutics and Pfizer's acquisition of Biohaven Pharmaceuticals, Davis J. Wang, co-head of Sullivan & Cromwell LLP's tax group, has been recognized...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login